Crossmark

Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia

Crossref DOI link: https://doi.org/10.1016/j.medcle.2021.05.024

Published Print: 2022-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Pereña, Laura

Ramos Sesma, Violeta

Tornero Divieso, María Lucía

Lluna Carrascosa, Alfonso

Velasco Fuentes, Sara

Parra-Ruiz, Jorge
License Information

Text and Data Mining valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01
More Information

This article is maintained by: Elsevier

Article Title: Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2021.05.024

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2021.05.015

Content Type: simple-article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.